- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有47家主力机构披露2025-06-30报告期持股数据，持仓量总计5031.91万股，占流通A股18.48%
- 波段诊断：
-
技术面诊股
诊断结果：7.3技术面打败了64%的股票
技术面评分前10的股票
近期的平均成本为7.80元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为7.80元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.80","date":1760948171,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2025.10.21","stock":"2.34","trade":null,"ind":"2.06"},{"date":"2025.10.20","stock":"2.26","trade":null,"ind":"0.98"},{"date":"2025.10.17","stock":"-1.05","trade":null,"ind":"-3.04"},{"date":"2025.10.16","stock":"-0.91","trade":null,"ind":"-0.25"},{"date":"2025.10.15","stock":"0.52","trade":null,"ind":"1.73"},{"date":"2025.10.14","stock":"0.53","trade":null,"ind":"-2.54"},{"date":"2025.10.13","stock":"0.26","trade":null,"ind":"-0.93"},{"date":"2025.10.10","stock":"0.40","trade":null,"ind":"-2.70"},{"date":"2025.10.09","stock":"-1.69","trade":null,"ind":"1.47"},{"date":"2025.09.30","stock":"0.00","trade":null,"ind":"0.35"},{"date":"2025.09.29","stock":"0.92","trade":null,"ind":"2.05"},{"date":"2025.09.26","stock":"-0.52","trade":null,"ind":"-1.76"},{"date":"2025.09.25","stock":"-1.04","trade":null,"ind":"0.67"},{"date":"2025.09.24","stock":"1.31","trade":null,"ind":"1.80"},{"date":"2025.09.23","stock":"-1.80","trade":null,"ind":"-0.29"},{"date":"2025.09.22","stock":"-1.40","trade":null,"ind":"0.67"},{"date":"2025.09.19","stock":"-0.63","trade":null,"ind":"-0.04"},{"date":"2025.09.18","stock":"-3.06","trade":null,"ind":"-1.06"},{"date":"2025.09.17","stock":"0.37","trade":null,"ind":"1.16"},{"date":"2025.09.16","stock":"1.88","trade":null,"ind":"0.45"},{"date":"2025.09.15","stock":"-1.36","trade":null,"ind":"0.63"}]
阳普医疗,深证成指,医疗器械指数
压力支撑
该股压力位为7.72元，支撑位为7.57元。
[{"text":"\u538b\u529b\u4f4d","value":"7.72","date":1760976000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.57","date":1760976000,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.6资金面打败了73%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月21日 20:33
| 机构今日流向(万元) | 640.72 | 机构5日流向(万元) | -1490.82 |
| 机构10日流向(万元) | -3914.88 | 机构20日流向(万元) | -10693.13 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1230.56万股，其中基金净增仓3家，主力净增仓32家，有一定的中长期投资价值。
截止2025-06-30，共47家主力机构（基金45家，QFII1家，一般法人1家），持仓量总计5031.91万股，占流通A股18.48%
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 100.57万股
减仓：2家 ，减持 4.28万股
新出现在主力名单中：38家 ，持有1484.21万股
从主力名单中消失：6家 ，原持有349.94万股
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 100.57万股
减仓：2家 ，减持 4.28万股
新出现在主力名单中：38家 ，持有1484.21万股
从主力名单中消失：6家 ，原持有349.94万股
消息面诊股
诊断结果：5.5消息面打败了25%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 阳普医疗：全资子公司收到医疗器械变更注册文件及完成
2025-09-11 - 珠海国企改革进行时：大横琴集团划转至珠光集团，世联
2025-09-10 - 阳普医疗在南非开普敦国际舞台绽放
2025-09-05 - 67家医疗器械公司发布半年报，4家净利润增长翻倍！
2025-08-27 - “智启未来 聚势共创”圆满收官，共绘医学装备智慧融
2025-08-18 - 阳普医疗半年报净利大增 高管层持续调整
2025-08-18 - 阳普医疗上半年扭亏为盈1527万元 费用全面下降
2025-08-17 - 股东追踪|邓冠华等新进阳普医疗前十大流通股东
2025-08-15 - 这些行业上市公司中期业绩翻倍 药企密集扭亏
2025-08-14 - 财报速递：阳普医疗2025年半年度净利润1526.
2025-08-16
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-15 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-25 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-04-11 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-02-28 |
| 重大利空 | 业绩预告 | 预计增亏 | 2025-01-17 |
| 一般消息 | 高管变动 | 因工作调整 | 2024-12-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了46%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.10.21","price":"2.06","value":null},{"date":"2025.10.20","price":"0.98","value":null},{"date":"2025.10.17","price":"-3.04","value":null},{"date":"2025.10.16","price":"-0.25","value":null},{"date":"2025.10.15","price":"1.73","value":null},{"date":"2025.10.14","price":"-2.54","value":null},{"date":"2025.10.13","price":"-0.93","value":null},{"date":"2025.10.10","price":"-2.70","value":null},{"date":"2025.10.09","price":"1.47","value":null},{"date":"2025.09.30","price":"0.35","value":null},{"date":"2025.09.29","price":"2.05","value":null},{"date":"2025.09.26","price":"-1.76","value":null},{"date":"2025.09.25","price":"0.67","value":null},{"date":"2025.09.24","price":"1.80","value":null},{"date":"2025.09.23","price":"-0.29","value":null},{"date":"2025.09.22","price":"0.67","value":null},{"date":"2025.09.19","price":"-0.04","value":null},{"date":"2025.09.18","price":"-1.06","value":null},{"date":"2025.09.17","price":"1.16","value":null},{"date":"2025.09.16","price":"0.45","value":null},{"date":"2025.09.15","price":"0.63","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 振德医疗 | 86.12% | 7.62% | 6.5分 |
| 2 | 春立医疗 | 16.72% | 18.98% | 6.7分 |
| 3 | 英科医疗 | 14.29% | -4.27% | 5.6分 |
| 4 | 祥生医疗 | 14.15% | 6.04% | 6.4分 |
| 5 | 楚天科技 | 11.96% | -0.22% | 4.6分 |
| 6 | 海泰新光 | 11.08% | 0.38% | 5.8分 |
| 8 | 可孚医疗 | 9.35% | 6.78% | 6.6分 |
| 10 | 采纳股份 | 7.17% | 7.94% | 5.6分 |
| 12 | ST凯利 | 5.12% | 1.88% | 5.6分 |
| 14 | 东富龙 | 3.87% | 2.85% | 5.5分 |
| 16 | 九安医疗 | 3.34% | 1.36% | 5.7分 |
| 18 | 南卫股份 | 2.40% | 4.07% | 6.2分 |
| 20 | 海尔生物 | 2.13% | 4.42% | 6.0分 |
| 22 | 睿昂基因 | 1.80% | 3.34% | 5.9分 |
| 24 | 麦澜德 | 1.56% | 1.20% | 5.7分 |
| 26 | 麦克奥迪 | 1.36% | -5.65% | 5.2分 |
| 28 | 明德生物 | 1.03% | 3.31% | 5.3分 |
| 30 | 三友医疗 | 1.00% | 1.35% | 6.0分 |
| 32 | 奥泰生物 | 0.57% | 1.36% | 5.8分 |
| 34 | - | 0.41% | -10.03% | 分 |
| 36 | 圣湘生物 | 0.10% | -3.10% | 5.1分 |
| 38 | 维力医疗 | -0.56% | 7.35% | 6.4分 |
| 40 | 澳华内镜 | -0.61% | 1.45% | 4.6分 |
| 42 | 奥美医疗 | -0.80% | 2.90% | 6.3分 |
| 44 | 国发股份 | -0.85% | 3.17% | 5.9分 |
| 46 | 爱朋医疗 | -1.11% | 7.06% | 5.3分 |
| 48 | 乐普医疗 | -1.20% | 5.58% | 5.8分 |
| 50 | 安旭生物 | -1.27% | 0.89% | 5.4分 |
| 52 | 华大智造 | -1.28% | -1.88% | 5.0分 |
| 54 | 普门科技 | -1.70% | -3.54% | 5.4分 |
| 56 | 赛科希德 | -1.87% | 2.14% | 5.5分 |
| 58 | 佰仁医疗 | -2.05% | 4.68% | 5.7分 |
| 60 | 冠昊生物 | -2.12% | 5.29% | 6.4分 |
| 62 | 山外山 | -2.19% | -2.90% | 5.8分 |
| 64 | 科华生物 | -2.23% | 3.62% | 5.5分 |
| 66 | 迪瑞医疗 | -2.44% | -1.02% | 4.9分 |
| 68 | 尚荣医疗 | -2.61% | 4.33% | 5.6分 |
| 70 | 健尔康 | -2.79% | 2.52% | 5.6分 |
| 72 | 中红医疗 | -3.00% | 1.34% | 5.9分 |
| 74 | 凯普生物 | -3.21% | 2.51% | 5.3分 |
| 76 | 天益医疗 | -3.29% | 5.83% | 5.9分 |
| 78 | 南微医学 | -3.42% | -3.53% | 5.8分 |
| 80 | 九强生物 | -3.48% | 0.91% | 5.6分 |
| 82 | 戴维医疗 | -3.69% | 3.98% | 6.0分 |
| 84 | 正海生物 | -3.87% | 0.86% | 5.3分 |
| 86 | 中源协和 | -4.17% | -2.39% | 5.1分 |
| 88 | 康众医疗 | -4.33% | 7.47% | 5.7分 |
| 90 | 迈克生物 | -4.52% | 1.84% | 5.6分 |
| 92 | - | -4.74% | -0.96% | 分 |
| 94 | 伟思医疗 | -5.12% | -2.35% | 5.6分 |
| 96 | 安必平 | -5.47% | -2.12% | 5.0分 |
| 98 | 理邦仪器 | -5.57% | 2.42% | 6.1分 |
| 100 | 康拓医疗 | -5.86% | 0.46% | 5.8分 |
| 102 | 万泰生物 | -6.28% | -1.49% | 4.9分 |
| 104 | 易瑞生物 | -6.38% | 7.53% | 6.0分 |
| 106 | 东方生物 | -6.45% | -0.16% | 5.1分 |
| 108 | 赛诺医疗 | -6.57% | -1.08% | 5.5分 |
| 110 | 开立医疗 | -6.90% | -0.54% | 5.1分 |
| 112 | 昊海生科 | -7.09% | -0.77% | 5.3分 |
| 114 | - | -7.42% | 2.64% | 分 |
| 116 | 济高发展 | -7.87% | 2.60% | 4.6分 |
| 118 | - | -8.33% | 3.51% | 分 |
| 120 | 健帆生物 | -8.59% | -1.10% | 5.3分 |
| 122 | 新产业 | -9.90% | -2.26% | 5.3分 |
| 124 | 天臣医疗 | -10.30% | 4.68% | 5.8分 |
| 126 | 安杰思 | -10.97% | -2.22% | 5.3分 |
| 128 | 之江生物 | -11.85% | 2.90% | 4.6分 |
| 130 | 美好医疗 | -13.43% | -0.71% | 5.6分 |
| 132 | 济民健康 | -23.57% | 3.41% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 65/247 ， 85/247。
[{"date":"2025-06-30","value":"2.48","vol":"2.27"},{"date":"2025-03-31","value":"1.28","vol":"1.15"},{"date":"2024-12-31","value":"-17.73","vol":"0.53"},{"date":"2024-09-30","value":"-6.06","vol":"4.75"},{"date":"2024-06-30","value":"-0.73","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.48 | 1.28 | -17.73 | -6.06 | -0.73 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"41.38","vol":"52.10"},{"date":"2025-03-31","value":"40.19","vol":"51.81"},{"date":"2024-12-31","value":"41.39","vol":"52.63"},{"date":"2024-09-30","value":"40.04","vol":"53.58"},{"date":"2024-06-30","value":"40.04","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
41.38 | 40.19 | 41.39 | 40.04 | 40.04 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 108/247 ， 2/247。
[{"date":"2025-06-30","value":"-21.22","vol":"-1.71"},{"date":"2025-03-31","value":"-18.15","vol":"-0.92"},{"date":"2024-12-31","value":"-9.82","vol":"0.64"},{"date":"2024-09-30","value":"-10.78","vol":"0.79"},{"date":"2024-06-30","value":"-8.32","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-21.22 | -18.15 | -9.82 | -10.78 | -8.32 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"389.40","vol":"-20.27"},{"date":"2025-03-31","value":"344.71","vol":"-4.25"},{"date":"2024-12-31","value":"-86.55","vol":"-24.11"},{"date":"2024-09-30","value":"-1434.95","vol":"-20.40"},{"date":"2024-06-30","value":"-150.41","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
389.40 | 344.71 | -86.55 | -1434.95 | -150.41 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 38/247 ， 40/247。
[{"date":"2025-06-30","value":"0.20","vol":"0.17"},{"date":"2025-03-31","value":"0.10","vol":"0.08"},{"date":"2024-12-31","value":"0.44","vol":"0.35"},{"date":"2024-09-30","value":"0.31","vol":"0.26"},{"date":"2024-06-30","value":"0.21","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.10 | 0.44 | 0.31 | 0.21 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.33","vol":"1.13"},{"date":"2025-03-31","value":"0.67","vol":"0.55"},{"date":"2024-12-31","value":"2.90","vol":"2.33"},{"date":"2024-09-30","value":"1.90","vol":"1.67"},{"date":"2024-06-30","value":"1.34","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.33 | 0.67 | 2.90 | 1.90 | 1.34 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 96/247 ， 44/247。
[{"date":"2025-06-30","value":"3.04","vol":"15.06"},{"date":"2025-03-31","value":"11.77","vol":"4.01"},{"date":"2024-12-31","value":"24.42","vol":"29.58"},{"date":"2024-09-30","value":"19.92","vol":"15.37"},{"date":"2024-06-30","value":"0.81","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.04 | 11.77 | 24.42 | 19.92 | 0.81 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.81","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.22","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"1.58","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.81 | - | 1.22 | - | 1.58 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 28/247 ， 14/247。
[{"date":"2025-06-30","value":"1.17","vol":"5.50"},{"date":"2025-03-31","value":"1.21","vol":"5.89"},{"date":"2024-12-31","value":"1.15","vol":"5.34"},{"date":"2024-09-30","value":"1.16","vol":"5.97"},{"date":"2024-06-30","value":"1.17","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.17 | 1.21 | 1.15 | 1.16 | 1.17 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.73","vol":"4.40"},{"date":"2025-03-31","value":"0.77","vol":"4.77"},{"date":"2024-12-31","value":"0.81","vol":"4.32"},{"date":"2024-09-30","value":"0.79","vol":"4.82"},{"date":"2024-06-30","value":"0.79","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.73 | 0.77 | 0.81 | 0.79 | 0.79 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 5/247 ， 9/247。
[{"date":"2025-06-30","value":"41.33","vol":"22.01"},{"date":"2025-03-31","value":"42.74","vol":"21.24"},{"date":"2024-12-31","value":"48.25","vol":"21.92"},{"date":"2024-09-30","value":"46.07","vol":"21.09"},{"date":"2024-06-30","value":"42.82","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
41.33 | 42.74 | 48.25 | 46.07 | 42.82 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.74","vol":"0.58"},{"date":"2025-03-31","value":"0.79","vol":"0.57"},{"date":"2024-12-31","value":"0.99","vol":"0.55"},{"date":"2024-09-30","value":"0.90","vol":"0.38"},{"date":"2024-06-30","value":"0.79","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.74 | 0.79 | 0.99 | 0.90 | 0.79 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.19","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.98","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.63","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.18","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]